dxrules44

Have there been any approaches for a partnership or further clinical trials using multikine?

Is there a biomarker that suggests what patients will respond to the drug and what patients will not, e g hla-2?

Is it taking longer to recruit staff than initially expected?

There are many roles available in regards to the manufacturing of Multikine but no roles for sales/ sales force as such, how do you aim to commercialise this?

Is there any analysis or biomarker data to suggest if this can work with keytruda in the high risk arm for better treatment in that area